155
Views
35
CrossRef citations to date
0
Altmetric
Original

High-Risk Behaviors and Hospitalizations Among Gamma Hydroxybutyrate (GHB) Users

, Pharm.D., , Pharm.D., , Pharm.D., , Ph.D. & , M.D.
Pages 429-438 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

I. B. Anderson, S. Y. Kim-Katz, J. E. Dyer & P. D. Blanc. (2010) The impact of gamma hydroxybutyrate (GHB) legal restrictions on patterns of use: Results from an International Survey. Drugs: Education, Prevention and Policy 17:5, pages 455-469.
Read now
Edmund Silins, Jan Copeland & Paul Dillon. (2010) Perceptions of methamphetamine- and GHB-related presentations among emergency medicine healthcare professionals: An exploratory study. Drugs: Education, Prevention and Policy 17:2, pages 181-187.
Read now
Ilene B. Anderson, Susan Y. Kim-Katz, Jo Ellen Dyer, Gillian E. Earnest, John P. Lamb & Paul D. Blanc. (2009) Area-level socioeconomic status in relation to outcomes in γ-hydroxybutyrate intoxication. Clinical Toxicology 47:1, pages 48-57.
Read now
Judith C. Barker & Hadi Karsoho. (2008) Hazardous Use of Gamma Hydroxybutyrate: Driving Under the Influence. Substance Use & Misuse 43:11, pages 1507-1520.
Read now
Susan Y. Kim, Judith C. Barker, Ilene B. Anderson, Jo Ellen Dyer, Gillian Earnest & Paul D. Blanc. (2008) Systematic Assessment of Gamma Hydroxybutyrate (GHB) Effects During and After Acute Intoxication. American Journal on Addictions 17:4, pages 312-318.
Read now

Articles from other publishers (30)

Joseph J. Palamar, Nicole D. Fitzgerald, David J. Grundy, Joshua C. Black, Jennifer S. Jewell & Linda B. Cottler. (2022) Characteristics of poisonings involving ketamine in the United States, 2019–2021. Journal of Psychopharmacology 37:8, pages 802-808.
Crossref
B.A.G. Dijkstra, H. Beurmanjer, A.E. Goudriaan, A.F.A. Schellekens & E.A.G. Joosten. (2021) Unity in diversity: A systematic review on the GHB using population. International Journal of Drug Policy 94, pages 103230.
Crossref
Vivian Rodriguez-Cruz & Marilyn E. Morris. (2021) γ -Hydroxybutyric Acid–Ethanol Drug-Drug Interaction: Reversal of Toxicity with Monocarboxylate Transporter 1 Inhibitors . Journal of Pharmacology and Experimental Therapeutics 378:1, pages 42-50.
Crossref
Nisha V. Kwatra & Marilyn E. Morris. (2021) Toxicokinetic/Toxicodynamic Interaction Studies in Rats between the Drugs of Abuse γ-Hydroxybutyric Acid and Ketamine and Treatment Strategies for Overdose. Pharmaceutics 13:5, pages 741.
Crossref
Melanie A. Felmlee, Bridget L. Morse & Marilyn E. Morris. (2021) γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology. The AAPS Journal 23:1.
Crossref
Chan Seo, Myungjin Na, Jiyeun Jang, Meejung Park, Boyeon Choi, Sooyeun Lee & Man-Jeong Paik. (2018) Monitoring of altered amino acid metabolic pattern in rat urine following intraperitoneal injection with γ-hydroxybutyric acid. Metabolomics 14:9.
Crossref
Mohamed A. Hammoud, Adam Bourne, Lisa Maher, Fengyi Jin, Bridget Haire, Toby Lea, Louisa Degenhardt, Jeffrey Grierson & Garrett Prestage. (2018) Intensive sex partying with gamma-hydroxybutyrate: factors associated with using gamma-hydroxybutyrate for chemsex among Australian gay and bisexual men – results from the Flux Study. Sexual Health 15:2, pages 123.
Crossref
Desiree Madah-Amiri, Lars Myrmel & Guttorm Brattebø. (2017) Intoxication with GHB/GBL: characteristics and trends from ambulance-attended overdoses. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 25:1.
Crossref
David M. Wood. 2017. Critical Care Toxicology. Critical Care Toxicology 1555 1586 .
Oliver G. Bosch & Erich Seifritz. (2016) The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans. Brain Research Bulletin 126, pages 47-60.
Crossref
J.G.C. van Amsterdam, T.M. Brunt, M.T.B. McMaster & W. van den Brink. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse 453 459 .
David M. Wood. 2016. Critical Care Toxicology. Critical Care Toxicology 1 32 .
John M. Corkery, Barbara Loi, Hugh Claridge, Christine Goodair, Ornella Corazza, Simon Elliott & Fabrizio Schifano. (2015) Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use. Neuroscience & Biobehavioral Reviews 53, pages 52-78.
Crossref
Rama M. Kamal, Rouhollah Qurishi & Cornelis A.J. De Jong. (2015) Baclofen and γ-Hydroxybutyrate (GHB), a Dangerous Combination. Journal of Addiction Medicine 9:1, pages 75-77.
Crossref
Margareta Warrén Stomberg, Kai Knudsen, Henrik Stomberg & Ingela Skärsäter. (2014) Symptoms and signs in interpreting Gamma-hydroxybutyrate (GHB) intoxication - an explorative study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 22:1.
Crossref
Jan van Amsterdam, Tibor Brunt, Ed Pennings & Wim van den Brink. (2014) Risk assessment of GBL as a substitute for the illicit drug GHB in the Netherlands. A comparison of the risks of GBL versus GHB. Regulatory Toxicology and Pharmacology 70:2, pages 507-513.
Crossref
Nisha Vijay & Marilyn E. Morris. (2014) Effect of 3,4-Methylenedioxymethamphetamine on the Toxicokinetics and Sedative Effects of the Drug of Abuse, γ-Hydroxybutyric Acid. Journal of Pharmaceutical Sciences 103:10, pages 3310-3315.
Crossref
M. E. Sutter, J. Chenoweth & T. E. Albertson. (2013) Alternative Drugs of Abuse. Clinical Reviews in Allergy & Immunology 46:1, pages 3-18.
Crossref
John M. Roll, Thomas Newton, Joy Chudzynski, Jennifer M. Cameron, Sterling Mcpherson, Timothy Fong & Matt Torrington. (2013) PREFERENCE FOR GAMMA‐HYDROXYBUTYRATE (GHB) IN CURRENT USERS. Journal of the Experimental Analysis of Behavior 97:3, pages 323-331.
Crossref
Jan G.C. van Amsterdam, Tibor M. Brunt, Minni T.B. McMaster & Raymond J.M. Niesink. (2012) Possible long-term effects of γ-hydroxybutyric acid (GHB) due to neurotoxicity and overdose. Neuroscience & Biobehavioral Reviews 36:4, pages 1217-1227.
Crossref
Stanley M. Parsons. 2011. Forensic Chemistry Handbook. Forensic Chemistry Handbook 355 434 .
Laurent Karila & Michel Reynaud. (2010) GHB and synthetic cathinones: clinical effects and potential consequences. Drug Testing and Analysis 3:9, pages 552-559.
Crossref
David M. Wood, Alan D. Brailsford & Paul I. Dargan. (2011) Acute toxicity and withdrawal syndromes related to gamma‐hydroxybutyrate (GHB) and its analogues gamma‐butyrolactone (GBL) and 1,4‐butanediol (1,4‐BD). Drug Testing and Analysis 3:7-8, pages 417-425.
Crossref
Deborah L. Zvosec, Stephen W. Smith, Trinka Porrata, A. Quinn Strobl & Jo Ellen Dyer. (2011) Case series of 226 γ-hydroxybutyrate–associated deaths: lethal toxicity and trauma. The American Journal of Emergency Medicine 29:3, pages 319-332.
Crossref
G. Laux & H. Berzewski. 2011. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie 2717 2749 .
Laurent Karila, Johanne Novarin, Bruno Megarbane, Olivier Cottencin, Sylvain Dally, William Lowenstein & Michel Reynaud. (2009) Acide gamma-hydroxy-butyrique (GHB) : plus qu’un agent de soumission chimique, une véritable source d’addiction. La Presse Médicale 38:10, pages 1526-1538.
Crossref
Lawrence P. Carter, Daniel Pardi, Jane Gorsline & Roland R. Griffiths. (2009) Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem®): Differences in characteristics and misuse. Drug and Alcohol Dependence 104:1-2, pages 1-10.
Crossref
Lawrence P. Carter, Wouter Koek & Charles P. France. (2009) Behavioral analyses of GHB: Receptor mechanisms. Pharmacology & Therapeutics 121:1, pages 100-114.
Crossref
Joshua T. Kantrowitz, Leslie Citrome & Daniel C. Javitt. (2009) A review of tolerability and abuse liability of γ-hydroxybutyric acid for insomnia in patients with schizophrenia. Clinical Therapeutics 31, pages 1360-1373.
Crossref
Kit Sang Leung & Linda B Cottler. (2008) Ecstasy and other club drugs: a review of recent epidemiologic studies. Current Opinion in Psychiatry 21:3, pages 234-241.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.